Skip to main content
Medical information Clinical review pending

Diagnostic Testing

Immunophenotyping By Flow Cytometry CD36 Test

The Immunophenotyping By Flow Cytometry CD36 Test helps identify specific cell types in blood or bone marrow, aiding in the diagnosis and monitoring of blood disorders and cancers.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
3 mL (2 mL min.) whole blood in 1 Lavender Top (EDTA) tube, OR 3 mL (2 mL min.) whole blood in 1 Green Top (Sodium Heparin) tube, OR 2 mL (1 mL min.) Bone marrow in 1 Green Top (Sodium Heparin) tube.
Results
Confirm with the laboratory before booking.
Preparation
No special preparation is required for this test. Please inform the laboratory of any medications you are taking.
Test priceKSh 7,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Immunophenotyping By Flow Cytometry CD36 Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Diagnosis of leukemia
  • ✓Diagnosis of lymphoma
  • ✓Monitoring known blood cancers
  • ✓Investigating unexplained blood cell abnormalities
  • ✓Assessing response to cancer treatment
  • ✓Evaluating patients with symptoms suggestive of blood disorders
02

In plain language

What this test helps you understand

This test aids in the diagnosis, classification, and monitoring of hematological malignancies and other blood disorders by identifying specific cell populations based on CD36 antigen expression.
The Immunophenotyping By Flow Cytometry CD36 Test is a diagnostic procedure used in oncology. It uses flow cytometry to analyze cells in blood and bone marrow samples. This test looks for the presence of the CD36 antigen on cells, which helps healthcare providers understand various blood disorders and cancers.

Understanding the cellular makeup of blood and bone marrow is important for diagnosing and managing cancers. This test helps classify leukemias, lymphomas, and other malignancies, allowing doctors to plan effective treatments.

This test specifically measures the CD36 antigen on the surface of cells. The results can indicate the presence of abnormal cells that might suggest cancer.

This test is often recommended for individuals with symptoms or risk factors for blood cancers, such as unexplained fatigue, frequent infections, unusual bleeding or bruising, swollen lymph nodes, or a family history of blood disorders. If you have concerns, please consult your doctor.

Benefits of this test include early detection of blood cancers, accurate classification of blood disorders, guidance for treatment, and monitoring disease progression.

Results are typically available quickly. Your healthcare provider will discuss the results with you and explain what they mean for your health.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo special preparation is required for this test. Please inform the laboratory of any medications you are taking.
Sample3 mL (2 mL min.) whole blood in 1 Lavender Top (EDTA) tube, OR 3 mL (2 mL min.) whole blood in 1 Green Top (Sodium Heparin) tube, OR 2 mL (1 mL min.) Bone marrow in 1 Green Top (Sodium Heparin) tube.
MethodologyFlow Cytometry
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test identifies the presence or absence of the CD36 antigen. Results must be interpreted in the context of the patient's clinical picture and other laboratory findings. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

Immunophenotyping is a laboratory technique used to identify cells based on the molecules (antigens) they express on their surface or inside them. This test uses flow cytometry to analyze these markers.
CD36 is a protein found on the surface of certain cells. Its presence or absence, and the level of expression, can help identify specific types of blood cells and certain cancers.
The blood draw is a routine procedure with minimal discomfort. Bone marrow aspiration, if required, is a more involved procedure performed by a specialist.
Results are typically reported as the percentage of cells expressing the CD36 antigen. Your doctor will interpret these results in the context of your overall health.
Fasting is generally not required for this test.
Samples should be shipped immediately at 18°C to 22°C and must not be refrigerated or frozen. Please follow the specific instructions provided by the laboratory.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp